Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.
暂无分享,去创建一个
Jeffrey W. Clark | R. Jain | R. Bentley | C. Willett | D. Chung | Lei Xu | M. Ancukiewicz | D. Duda | G. Lauwers | B. Czito | E. di Tomaso | Rekha Samuel | P. Shellito | M. Poleski | Pei-Chun Lin